AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics
Clinical trial NCT05281601 · COMPLETED
Trial details
- NCT number
- NCT05281601
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-04-16
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.